The European initiative for quality management in lung cancer care.

Authors : Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert AP, Milroy R, Paesmans M, Peake M, Putora PM, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand TE, Taright S, Thomas M, Van Schil PE, Vansteenkiste JF, Wiewrodt R, Sculier JP
Year : 2014
Journal : Eur. Respir. J.
Volume : 43(5)
Pages : 1254-1277

Oncological intensive care: 2012 year's review].

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2014
Journal : Rev Med Brux
Volume : 35(1)
Pages : 22-7

Contribution of identification of occupational exposure in thoracic oncology: A Belgian experience.

Authors : Morelle I, Berghmans T, CsToth I, Sculier JP, Meert AP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(3)
Pages : 221-9

Updates in oncology.

Authors : Sculier JP, Meert AP, Berghmans T
Year : 2014
Journal : Eur Respir Rev
Volume : 23(131)
Pages : 69-78

TNM Classification and Clinicopathological Factors: What Is Helpful for Adjuvant Chemotherapy Decision after Lung Cancer Resection?

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2014
Journal : J Thorac Oncol
Volume : 9(3)
Pages : 266-70

Pulmonary Malignancies” “Pulmonary complications of HIV. Edited by Charles Feldman, Eva Polverino, Julio A. Ramirez. ERS/Monograph 66 (chapt 14)

Authors : Sculier JP, Meuleman N, Meert AP, Berghmans T
Year : 2014
Journal : Book
Volume : chapt 14
Pages : 186-198

Contribution of mineralogical analysis in thoraciconcology: The example of asbestos. Answer from Morelle et al.

Authors : Morelle I, Berghmans T, CsToth I, Sculier JP, Meert AP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(9)
Pages : 875-6

The patient with lung cancer in intensive care.

Authors : Meert AP, Berghmans T, Sculier JP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(10)
Pages : 961-974

Noninvasive mechanical ventilation in patients having declined tracheal intubation.

Authors : Azoulay E, Kouatchet A, Jaber S, Lambert J, Meziani F, Schmidt M, Schnell D, Mortaza S, Conseil M, Tchenio X, Herbecq P, Andrivet P, Guerot E, Lafabrie A, Perbet S, Camous L, Janssen-Langenstein R, Collet F, Messika J, Legriel S, Fabre X, Guisset O, Touati S, Kilani S, Alves M, Mercat A, Similowski T, Papazian L, Meert AP, Chevret S, Schlemmer B, Brochard L, Demoule A
Year : 2013
Journal : Intensive Care Med
Volume : 39(2)
Pages : 292-301

Thoracic Oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe.

Authors : Gamarra F, Boffetta P, De Ruysscher D, Felip E, Gaga M, Grigoriu B, Huber RM, Janes SM, Marquette CH, Massard G, Noel JL, Sculier JP, Meert AP
Year : 2013
Journal : Eur. Respir. J.
Volume : 42(3)
Pages : 568-71

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Authors : Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, CsToth I, Dernies T, Toussaint L, Leclercq N, Sculier JP
Year : 2013
Journal : Lung Cancer
Volume : 82(2)
Pages : 340-5

Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from france and belgium--a groupe de recherche respiratoire en reanimation onco-hematologique study.

Authors : Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(22)
Pages : 2810-8

Aetiological diagnosis of acute respiratory failure in critical care oncology.

Authors : Meert AP, Sculier JP
Year : 2013
Journal : Eur. Respir. J.
Volume : 42(2)
Pages : 299-301

Thoracic oncology: annual review.

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2013
Journal : Rev Med Brux
Volume : 34(2)
Pages : 100-11

An atypical presentation of bronchial adenocarcinoma.

Authors : Langouo Fontsa M, CsToth I, Berghmans T, Feoli F, Meert AP
Year : 2013
Journal : Rev Med Brux
Volume : 34(3)
Pages : 181-3

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Authors : Berghmans T, Lafitte JJ, Scherpereel A, Paesmans M, Lecomte J, Marco VG, Meert AP, Leclercq N, Sculier JP
Year : 2013
Journal : Anticancer Res
Volume : 33(12)
Pages : 5477-82

The lung cancer patient at the emergency department: A three-year retrospective study.

Authors : Gorham J, Ameye L, Berghmans T, Sculier JP, Meert AP
Year : 2013
Journal : Lung Cancer
Volume : 80(2)
Pages : 203-8.

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Authors : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Year : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Authors : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Year : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pages : 21-7

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Authors : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Year : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28